![STOCKTALK CENTRAL SPECIAL ALERT]() |
| NEWS ALERT! |
| IBXG Group, Inc. (OTCBB: IBXG) |
Near Term Price Projection: $.38 |
|
| SHARES OUTSTANDING: |
50 million |
| APPROX. FLOAT: |
20 million |
| Near Term Price Proj.: |
$.38 |
|
| A Few Reasons To Own IBXG |
|
- IBXG is an emerging growth company in the trillion-dollar healthcare industry.
- IBXG is coming off its fourth quarter in a row of increasing revenues and its second consecutive profitable quarter. IBXG experienced a 50% gain in third quarter revenue.
- IBXG estimated EPS for all of 2002 is estimated to be $.01 per share.
- IBXG is currently cash flow positive. IBXG is making acquisitions and expanding its infrastructure while vigorously pursuing the Marketing Plan.
- IBXG is a results-oriented company with three integrated divisions - Healthcare Transaction Services, Physical Therapy & Occupational Medicine, and Technology/Information Services.
- IBXG has established a strong market niche in the area of Healthcare Transaction Services.
- IBXG recently began managing its largest receivables management project ever totaling $39 million from Intracoastal Health Systems, Inc. of West Palm Beach, Florida.
- IBXG has implemented a clear-cut strategic plan to expand its capabilities in the area of Physical Therapy and Occupational Medicine.
- IBXG has developed and recently commenced marketing an innovative web-based inventory management application for the $1.5 billion durable medical equipment (DME) industry.
- IBXG has developed and deployed a proprietary online consumer medical records service throughout the U.S. The technology is being utilized by several affinity groups, including one of the largest credit card companies in the world.
- IBXG's internal compliance program has been certified as meeting all current requirements of the Federal Health Insurance Portability and Accountability Act (HIPAA).
|
|
|
Great News! IBXG Continues to Meet or Exceed its Sales and Revenue Goals.
With Today's PR, not only does IBXG finds ways to make money out of one of life's greatest pleasures, But IBXG through a targeted Marketing Campaign has Maintained its Sales goals for its TheraTouch Massage Device.
TheraTouch is an individual-controlled body Massage Device that IBXG has Improved and was just recently Approved by the U.S. Patent and Trademark Office.
As quoted by Evan R. Brovenick, President and CEO of IBXG:
"Massage has long been recognized as an essential healing tool for people who have suffered from a variety of injuries, as well as a stress-reliever for many others. TheraTouch will make clinical-style massage accessible to segments of our population who, until now, have been unable to take advantage of it."
According to the PR below ""The massage industry in the United States represents almost $6 billion a year."
With IBXG growing by potential acquisitions, it would seem to us, with More and More People Recognizing the Healing Power of Massage, Coupled with the Growth of IBXG, Sales and Revenues for IBXG Should Exceed its Goals Over The Near Term.
In Our Last Few Profiles We Spoke About IBXG Having Some Of The KEY INGREDIENT's TO THE SUCCESS FOR ANY BUSINESS, Management, Timing, Satisfied Customers,
Now Add Exceeding Projected Sales Goals, and It Seems To Us That IBXG IS a Stock To Watch Over The Near Term.
WE CONTINUE TO MAKE THIS ARGUMENT:
According to a March 17th, 2003 PR from IBXG whereby IBXG raised revenue guidance for this year from $11 Million Dollars to $14 Million Dollars, and since then has announced Additional Revenue Deals such as today's PR, there has been virtually NO CHANGE IN IBXG's STOCK PRICE.
If we now compare IBXG to its peers, the peer group trades in the marketplace (according to Multex) at 27 times earnings and about 6 times sales, then applying these multiples to IBXG on an EPS basis IBXG should be worth TODAY $.47 Per Share, and on a multiple of sales IBXG should be worth TODAY almost $1.45 Per Share.
IBXG's Market Cap is about $6 Million Dollars with estimating $14 Million Dollars Plus in Revenues for 2003, and expecting to Earn over $1 Million Dollars.
IN OUR OPINION, AT CURRENT STOCK PRICE LEVELS IBXG IS GROSSLY UNDERVALUED, AND WE BELIEVE IS DO FOR A POP TO HIGHER STOCK MARKET VALUATION'S AND HOPEFULLY SOON.
So keep a Real, Real Close Eye on IBXG as we think MORE PR IS LIKELY FORTHCOMING, and as always,
Watch This Stock Trade.
|
|
IBX GROUP GETS APPROVAL FOR THERATOUCH PATENT, PLANS ROLL-OUT OF MASSAGE DEVICE NOV. 1 DEERFIELD BEACH, Fla., Oct. 6, 2003 - iBX Group, Inc. (OTC Bulletin Board: IBXG), a South Florida corporation on the leading edge of the exploding physical therapy and rehabilitation industry, was notified last week that the patent application for its TheraTouch individual-controlled body massage device was approved by the U.S. Patent and Trademark Office in time for a Nov. 1 product roll-out.
The apparatus, priced at $12,995, was designed for use in a variety of clinical and leisure settings. A targeted marketing campaign has enabled the company to maintain its earlier sales goal of 100 units during the next year. iBX expects that the majority of the units will be distributed through an in-house leasing program, with delivery beginning ahead of schedule in less than a month. This will empower the company's physical therapy and rehabilitation division to exceed its projected revenue of $5 million for 2004.
"The massage industry in the United States represents almost $6 billion a year, and we believe demand will grow even stronger as insurance companies continue to recognize the cost savings of providing massage benefits," said Evan R. Brovenick, president and CEO of iBX. "Massage has long been recognized as an essential healing tool for people who have suffered from a variety of injuries, as well as a stress-reliever for many others. TheraTouch will make clinical-style massage accessible to segments of our population who, until now, have been unable to take advantage of it."
"Since acquiring the rights to this unique device several months ago, we've made a number of improvements that we believe will increase the potential of TheraTouch as a permanent fixture in clinical and rehabilitative settings," Brovenick said. "We also envision this product as a huge source of income at locations such as country clubs, resorts, cruise ships, health clubs, airports and truck stops."
TheraTouch provides users with a complete clinical-style massage encompassing all major muscle areas on the back from neck to calf and allows healthcare professionals to program customized therapy sessions for patients using a variety of speeds, intensities and massage heads. The units, which are easily adjustable by users, are also ideal for unattended use.
The product will be prominently featured at iBX's network of Florida HealthSource centers, including its flagship clinic in Boca Raton. The multidisciplinary centers offer a variety of physical therapy, occupational medicine and wellness services in a relaxed, upscale setting.
Based in Deerfield Beach, Florida, iBX Group Inc. develops and deploys creative, cost-effective methods for integrating financial, administrative and information services for the healthcare industry. iBX is a results-oriented company, consisting of five divisions - iBX Technologies, which enables healthcare organizations to maximize their accounts receivables; Florida HealthSource, a network of physical therapy and wellness centers; MediCompliant Solutions, which ensures medical practices' compliance with today's complex legal requirements; iBX Transcription Services, which offers physicians quick turn-around and Web-accessible progress reports; NursesSTAT, a revolutionary temporary staffing solution. IBX also owns SportshealthNet.com and TheNetDigest.com, interactive Web portals providing patients with comprehensive healthcare information and advice, and increasing physician referrals.
This release is comprised of interrelated information that must be interpreted in the context of all of the information provided and care should be exercised not to consider portions of this release out of context. This release contains certain "forward-looking statements and information" (as defined in the Private Securities Litigation Reform Act of 1995) concerning iBX Group, Inc. that are based on the beliefs of iBX Group, Inc.'s management, as well as assumptions made by and information currently available to iBX Group, Inc. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties detailed in iBX's filings with the Securities and Exchange Commission.
|
|
|
A Penny Stock with Multi-Dollar Potential: Trading Today in the Teens, but in our opinion, has Near-Term Potential for Huge Gains. IBXG may be one This Year's BIG surprises, making its current status as an undiscovered stock a rare timing opportunity for investors. Don't overlook this one! We not only consider IBXG an attractive "Emerging Growth Company," in our opinion, but also a "Value Stock" in view of its Revenues and Earnings. We believe that IBXG has targeted a creative niche in a hot sector.
Relative to comparative companies within the Healthcare Sector, IBXG could realize superior growth in business and earnings over the Near- Term period. A grouping of comparable companies within this Sector currently trades at an average price to revenues multiple of 6.19 X. For 2003 it is now estimated that IBXG should generate revenues of about $15 MILLION DOLLARS, and EPS of $0.02 Per Share.
If over the Near-Term IBXG were to trade in the Market Place at a 80% Discount to its Peers, then applying the comparative grouping's price to revenue multiples to IBXG we can arrive at a relative valuation of $.38 per share over the Near-Term.
|
|
|
"Patients want to do more of their medical management from home, doctors want to provide care quickly and efficiently, and hospitals and HMO’s want to keep costs down," says Jim Gabler, a research director for GartnerGroup’s Healthcare Industry Research and Advisory Services in Stamford, Conn. "All of this relates to technology, and it’s up to CIO’s to find a better way. People say healthcare revolves around doctors and patient care. Well in the months and years to come, the industry will revolve around technology and the CIO."
Given this climate in healthcare today, in our opinion, IBXG is an undervalued opportunity. IBXG is perfectly positioned to meet the needs of their target market with a strong commitment to their suite of services.
Aggressive investors looking for above-average return potential on a portion of their investment capital should give IBXG a serious look.
|
|
|
Are you a CEO of a Public Company or the Head of an Investor Relations or Public Relations Firm interested in Advertising your Company, or do you have a Product or Service that you would like Advertised to what we believe is the most Qualified & Largest Permission Based Opt-in Membership in the World, demographically speaking.
Unlike any other Email Marketer in the World, we can Guarantee Your Advertisement to be Opened and Read by over 1 Million of our Membership within 12 Hours of when we start to send Emails. We believe no other Email Marketer in the World can make this claim.
Yes, that�s right Guaranteed and Verified by what we believe is the Most Sophisticated Tracking Software in the World. Don�t be confused with other offers to Send Million�s of Emails as opposed to our offer whereby over 1 Million of our Members actually Open and Read Your Advertisement within 12 Hours of when we start to send emails, and many more thereafter.
We Don�t Come Cheap! We charge a premium for our services. So, only serious inquiries need to reply. If you are interested in learning more about our services, please click here and provide us with your contact information and some detail of what you are looking to advertise. If we are interested one of our representative�s will contact you shortly.
|
Disclaimer:
The purpose of this advertisement is to provide publicity for the advertised company, its products or services. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. StockTalk Central, and affiliates (STC), publishes reports providing information on selected companies that STC believes has investment potential. STC is not a registered investment advisor or broker-dealer. The above report is the opinion of STC and is not a guarantee that the target price for the stock will be met or that predicted business results for the company will occur. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. STC accepts no liability for any loss arising from an investor's reliance on or use of this report. An investment in IBXG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Previously, an affiliate of STC has been compensated two hundred forty-five thousand dollars by the company, and additionally received 9.2 million warrants exercisable into free trading shares of common stock of IBXG at ten cents per share and an additional 1 million warrants exercisable into free trading shares of common stock of IBXG at thirteen cents per share and an additional 2 million warrants exercisable into free trading shares of common stock of IBXG at five cents per share by a third party for the publication and circulation of previous reports, of which all the warrants have been exercised and the stock sold. In addition, IBXG has extended their agreement for the publication and circulation of this report, and an affiliate of STC has been compensated one hundred thousand dollars and received an additional 2 million warrants exercisable into free trading shares of IBXG at ten cents per share by a third party non-affiliate (TFST) and STC and affiliates have no relationship whatsoever to the third party. STC intends to sell all or a portion of the IBXG stock at or about the time of publication of this report. Subsequently STC may buy or sell shares of IBXG stock in the open market. Since an affiliate of STC has been compensated there is an inherent conflict of interest. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. For further details concerning these risks and uncertainties, see the SEC filings of IBXG including the company's most recent annual and quarterly reports.
|
|
|
